Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein

Vaccine

Volumn 20, Issue 5-6, 2001, Pages 789-796

  Moriya, Osamu ^a   Matsui, Masanori ^a   Osorio, Manuel ^b   Miyazawa, Hitoshi ^a   Rice, Charles M ^c   Feinstone, Stephen M ^d   Leppla, Stephen H ^b   Keith, Jerry M ^b   Akatsuka, Toshitaka ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Anthrax toxin; Cytotoxic T lymphocytes; Hepatitis C virus

Indexed keywords

ANTHRAX TOXIN; EPITOPE; HEPATITIS C VACCINE; HYBRID PROTEIN; LETHAL FACTOR HEPATITIS C ANTIGEN VACCINE; RECOMBINANT VACCINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG SAFETY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; LETHAL GENE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELL LINE; DENDRITIC CELLS; FEMALE; HEPACIVIRUS; IMMUNIZATION; MACROPHAGES; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL CORE PROTEINS; VIRAL HEPATITIS VACCINES;

EID: 0035852316     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00407-8     Document Type: Article

References (39)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. Hepatitis C virus infection is associated with development of hepatocellular carcinoma
3. Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease
4. T lymphocyte response to hepatitis C virus in different clinical courses of infection
5. Antigen recognition by class I-restricted T lymphocytes
6. Degradation of cell proteins and the generation of MHC class I-presented peptides
7. Induction of cytotoxic T cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus
8. Hepatitis C virus-specific CTL responses in PBL from chimpanzees with chronic hepatitis C: Determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC)
9. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
10. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity
11. Plasmid DNA-based immunization for hepatitis C virus structure proteins: Immune response in mice
12. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
13. Peptides fused to the amino-terminal end of diphtheria toxin are translocated to the cytosol
14. Targetted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin
15. Use of pertussis toxin vaccine molecule PT19K/129G to deliver peptide epitopes for stimulation of a cytotoxic T lymphocyte response
16. Delivery of antigens to the MHC class 1 pathway using bacterial toxins
17. Anthrax toxin-mediated delivery of a cytotoxic T cell epitope in vivo
18. Targeting HIV proteins to the major histocompatibility complex class 1 processing pathway with a novel gp120-anthrax toxin fusion protein
19. Fusions of anthrax toxin lethal factor with Shiga toxin and diphteria toxin enzymatic domains are toxic to mammalian cells
20. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo
21. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor
22. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans
23. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines
24. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1
25. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
26. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
27. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition
28. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes
29. The dendritic cell system and its role in immunogenicity
30. Immunobiology of dendritic cells
31. The HLA-A*0201-restricted H-Y antigen contains a postranslationally modified cysteine that significantly affects T cell recognition
32. Anthrax toxin mediated delivery in vivo and in vitro of a cytotoxic T-lymphocytes epitope from ovalbumin
33. Sequence analysis of the core gene of 14 hepatitis C virus genotypes
34. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
35. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
36. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA-A2.1 binding motif
37. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
38. Suppression of host immune response by the core protein of hepatitis C virus: Possible implications for hepatitis C virus persistence